Introduction
was evaluated for tumor cell lines from different histotypes using the Alamar blue assay. The essential oil, but not the constituents tested, presented promising cytotoxicity. Furthermore, mice inoculated with B16-F10 mouse melanoma were used to confirm its in vivo effectiveness. An in vivo antitumor study showed tumor growth inhibition rates of 1.68-38.61 % (50 and 100 mg/kg, respectively). In conclusion, the leaf essential oil of Z. brasiliensis presents trans-nerolidol, germacrene D, trans-caryophyllene, α-humulene, and farnesene as major constituents and is able to inhibit cell proliferation in cultures as well as in tumor growth in mice.
tion of the essential oil from the whole plant Z. diphylla (L.) Pers [10] . In this specie, 37 compounds comprising 96.3 % of the oil were identified by GC-MS. Monoterpenoids predominated the essential oil (83.9 %), and the major constituent was sabinene (43.1 %) followed by terpinene 4-ol (13.2 %), γ-terpinene (7.3 %), β-pinene (4.7 %), and δ-2-carene (3.7 %) [10] . The chemical composition was very different from the one described in our work. However, it is important to say that in this work the authors used the whole plant, while in our work we used only the leaves. On the other hand, most of the major compounds identified in the essential oil of Z. brasiliensis, such as trans-nerolidol, α-humulene, and trans-caryophyllene, were found as minor constituents in Z. diphylla. This work contributes to the chemical knowledge of the species belonging to the genus Zornia, in particular to the chemical composition of their essential oil, which is little explored. The cytotoxicity of the essential oil and some of its major constituents (trans-Nerolidol, trans-caryophyllene, and α-humulene) was evaluated for tumor cell lines from different histotypes using the Alamar blue assay. l " Table 2 shows the obtained IC 50 values. The IC 50 values ranged from 1.05 to 9.58 µg/mL on HepG2 and HL-60 cell lines for the essential oil, from 17.58 to > 25 µg/mL on K562 and B16-F10 cell lines for trans-nerolidol, from 12.82 to > 25 µg/mL on HepG2 and B16-F10 cell lines for trans-caryophyllene, from 4.37 to > 25 µg/mL on K562 and B16-F10 cell lines for α-humulene, respectively. 5-Fluorouracil (5-FU), used as the positive control, showed IC 50 values from 0.04 to 0.87 µg/mL for the HepG2 and B16-F10 cell lines, respectively. According to our preclinical anticancer drug screening program, only those extracts/ oils presenting IC 50 values below 30 µg/mL and pure compounds presenting IC 50 values below 4 µg/mL in tumor cell line assays are considered promising [11] [12] [13] [14] . Thus, the essential oil obtained from Z. brasiliensis presented promising results. Interestingly, the essential oil was not cytotoxic to non-tumor cells (PBMCs). On the other hand, this effect seems to be associated to a mixture of its major and minor constituents, since the pure compounds present only weak cytotoxicity (IC 50 > 4 µg/mL for all tumor cell lines tested). As cited above, the methanol extract of the aerial parts of Z. cf. brasiliensis has been reported to have a cytotoxic effect. The cytotoxic property was determined through the brine shrimp lethality test, and the lethal concentration was 7.2 µg/mL [6] . Arunkumar et al. [7] isolated a steroid positive compound from Z. diphylla that showed promising in vitro and in vivo anticancer activity to Daltonʼs lymphoma ascites cells and was devoid of any toxicity to mice in a short-term toxicity evaluation, indicating that this genus is a source of cytotoxic compounds. The cytotoxic activity of some major constituents present in the leaf essential oil of Z. brasiliensis has been previously assessed, but they showed IC 50 values > 4 µg/mL [13] [14] [15] [16] [17] [18] [19] . Herein, we confirmed that trans-caryophyllene, α-humulene, and trans-nerolidol presented only weak anticancer potential. To investigate whether Z. brasiliensis essential oil has in vivo antitumor activity, C57BL/6 mice were subcutaneously inoculated with B16-F10 melanoma and treated by the intraperitoneal route once a day for nine consecutive days with the essential oil. The essential oil was also able to inhibit tumor growth in mice. l " Fig. 1 shows the obtained inhibition. On the 16th day, the average tumor weight of the control mice was 3.87 ± 0.20 g. In the [19] presence of the essential oil (50 and 100 mg/kg), the average tumor weights were 3.80 ± 0.47 and 2.38 ± 0.27 g, respectively. Tumor growth inhibition rates were 1.68-38.61 %. 5-FU (25 mg/kg), used as the positive control, reduced the tumor weight by 43.11 %. Tumors obtained from all experimental groups showed typical tumoral proliferation consisting of round and oval cells exhibiting large nuclei, irregular or multiple nucleoli, and frequent abnormal mitoses. Some of these neoplastic cells also presented intracellular melanin pigment. The stroma was scarce but displayed many areas of congested vessels and inflammation. Systemic toxicological parameters were also examined in essential oil-treated mice. No significant changes in body and organ (liver, kidney, spleen, lungs, and heart) weight were seen in the essential oil-treated groups (p > 0.05, Table 1S , Supporting Information). Alkaline phosphatase, gamma-glutamyl transpeptidase, alanine aminotransferase, albumin, globulin, and total protein were measured to investigate liver function alterations, and urea and uric acid were measured to assess the renal parameters. Amylase was measured to investigate the pancreatic function, and creatine kinase was measured as a myocardial marker. Cholesterol and glucose were measured to investigate alterations on blood lipoids and sugar, respectively. Moreover, the total count of erythrocytes and leukocytes as well as a differential count of leukocytes, such as neutrophils, lymphocytes, monocytes, eosinophils, and basophils, were measured as a hematologic parameter. No statistically significant changes on peripheral blood biochemistry and hematologic parameters were seen in the essential oiltreated groups (p > 0.05, Tables 2S and 3S, Supporting Information, respectively). Histopathological analysis of the organs (liver, kidneys, spleen, lungs, and heart) showed that in the livers, hydropic changes, focal areas of isquemic necrosis, and vascular congestion were observed in all experimental groups but more intensely in 5-FUtreated mice. Essential oil-treated animals also exhibited chronic inflammation and focal hemorrhage. In the kidneys, hydropic change and vascular congestion were also observed in the groups, but more intensely in the essential oil-treated mice. In the spleens, hemosiderosis found in all the groups could be related with the hemocaterese function of this organ. Atelectasis, moderate emphysema, and focal hemorrhage were observed in the lungs of animals treated with the essential oil and 5-FU. In addition, inflammation, metastatic emboli, and nodules were also observed in the lungs of the essential oil-treated mice. In respect to this, B16-F10 cells present a higher metastatic potential [20] . Concerning the histopathological features mentioned above, it is important to note that reversible changes (e.g., hidropic change) are an acute cellular response to nonlethal injuries, and the cells are able to return to the homeostatic state when the stimulus ends. In addition, inflammation could be related with tissue necrosis, stressful conditions, and even circulating and metastasizing tumor cells. No histopathological alterations were observed in hearts for all treated groups.
In conclusion, the leaf essential oil of Z. brasiliensis presents trans-nerolidol, germacrene D, trans-caryophyllene, α-humulene, and farnesene as major constituents and is able to inhibit cell proliferation in cultures as well as in tumor growth in mice.
Materials and Methods

!
Cells
Tumor cells lines B16-F10 (mouse melanoma), HepG2 (human hepatocellular carcinoma), K562 (human chronic myelocytic leukemia), and HL-60 (human promyelocytic leukemia) were donated by Hospital A. C. Camargo, São Paulo, SP, Brazil. Cells were maintained in RPMI-1640 (Gibco-BRL) medium supplemented with 10 % FBS (Cultilab), 2 mM L-glutamine (Vetec Química Fina), and 50 µg/mL gentamycin (Novafarma). Adherent cells were harvested by treatment with 0.25 % trypsin EDTA solution (Gibco-BRL). All cell lines were cultured in cell culture flasks at 37°C in 5% CO 2 and subcultured every 3-4 days to maintain exponential growth. All experiments were conducted with cells in the exponential growth phase. All cell lines were tested for mycoplasma with a Lookout ® Mycoplasma qPCR detection kit (Sigma-Aldrich) and found to be free from contamination. Heparinized blood (from healthy, 20-to 35-year-old, nonsmoker donors who had not taken any drugs at least 15 days prior to sampling) was collected, and peripheral blood mononuclear cells (PBMCs) were isolated by a standard protocol by Ficoll (GE FicollPaque Plus) density gradient centrifugation. PBMCs were washed and resuspended at a concentration of 0.3 × 10 6 cells/mL in RPMI-1640 medium supplemented with 20% FBS, 2 mM glutamine, and 50 µg/mL gentamycin at 37°C with 5% CO 2 . In addition, concanavalin A (ConA, Sigma-Aldrich) was used as a mitogen to trigger cell division in T-lymphocytes. ConA (10 µg/mL) was added at the beginning of culture and, after 24 h, cells were treated with the test drugs. The Research Ethics Committee of the Oswaldo Cruz Foundation (Salvador, Bahia, Brazil) approved the experimental protocol (No. 031 019/2013). All participants signed their written informed consent to participate in the study. For all experiments, cell viability was performed by the Trypan blue exclusion assay. Over 90% of the cells were viable at the beginning of the culture.
Animals
A total of 36 specific-pathogen-free C57BL/6 mice (males, 25-30 g) was obtained and maintained at the animal facilities at the Gonçalo Moniz Research Center-FIOCRUZ (Salvador, Bahia, Brazil). Animals were housed in cages with free access to food and water, and kept under a 12:12-h light-dark cycle (lights on at . The animals were treated by intraperitoneal administration for nine consecutive days, starting one day after tumor implantation. 5-FU (25 mg/kg) was used as a positive control. The negative control was treated with the vehicle used for diluting the tested substance (5 % DMSO). Data are presented as mean ± SEM of nine animals. * P < 0.05 compared to the 5% DMSO group by AN-OVA followed by Student-Newman-Keuls.
6 : 00 a. m.). The animals were treated according to the ethical principles for animal experimentation of SBCAL (Brazilian Association of Laboratory Animal Science), Brazil. The local Animal Ethics Committee approved the experimental protocol (number 01/2013).
Botanical material
The leaves of Z. brasiliensis were collected in July 2012 at the ʼPo-voado Cajueiroʼ, city of Poço Redondo (coordinates: S 09°47′44.6″ and W 37°40′35.3″) in Sergipe State, Brazil. The identity of the plant was confirmed by Dr. Ana Paula do Nascimento Prata of the Department of Biology from Sergipe Federal University (UFS), Brazil, and a voucher specimen (24 663) 
Hydrodistillation of the essential oil
The essential oil from dried leaves (for 24 h) of Z. brasiliensis (200 g) was obtained by hydrodistillation for 3 h using a Clevenger-type apparatus. The essential oil was dried over anhydrous sodium sulfate and the percentage content was calculated on the basis of the dry weight of plant material. It was then stored in a freezer until analysis. The hydrodistillation was performed in triplicate.
GC-FID and GC-MS analyses of the essential oil
GC-FID and GC-MS analyses were performed on a Shimadzu GC-2010 Plus GCMS-QP2010 Ultra GC-FID, equipped with a Shimadzu AOC-20i auto-injector. The separation of the compounds was achieved on an RTx ® -5MS fused capillary chromatography column (30 m × 0.25 mm×0.25 µm film thickness) coated with 5 %-diphenyl-95%-dimethylpolysiloxane. Helium was the carrier gas at a 1.2 mL/min flow rate. The column temperature program was 40°C/4 min at a rate of 4°C/min to 240°C, then at 10°C/min to 280°C, and at 280°C/2 min. The injector and detector temperatures were 250°C and 280°C, respectively. Samples (10 mg/mL in CH 2 Cl 2 ) were injected with a 1 : 30 split ratio. Retention indices were generated with a standard solution of n-alkanes (C 8 -C 18 ). Peak areas and retention times were measured by an electronic integrator. The relative amounts of individual compounds were computed from GC peak areas without an FID response factor correction. MS were taken at 70 eV with scan intervals of 0.5 s and fragments from 40-550 Da. Essential oil components were identified by comparing the retention times of the GC peaks with standard compounds run under identical conditions, the retention indices [21] , and MS [22] with those in the literature, and the MS with those stored in the NIST and Wiley libraries.
Pure compounds
trans-Nerolidol (purity ≥ 85%), trans-caryophyllene (purity ≥ 98.5 %, sum of enantiomers) and α-humulene (purity ≥ 96 %) were obtained from Sigma-Aldrich. The chemical structures are presented in l " Fig. 2 .
In vitro cytotoxic activity assay 
In vivo antitumor activity assay
The in vivo antitumor effect was evaluated in C57BL/6 mice inoculated with B16-F10 melanoma. Tumor cells (2 × 10 6 cells per 500 µL) were implanted subcutaneously into the left hind groin of the mice. The essential oil was dissolved in 5 % DMSO and given to mice intraperitoneally once a day for nine consecutive days. At the beginning of the experiment, the mice were divided into four groups of nine animals as follows: group 1: animals treated by injection of vehicle 5 % DMSO; group 2: animals treated by injection of 5-FU (25 mg/kg); group 3: animals treated by injection of the essential oil (50 mg/kg); group 4: animals treated by injection of the essential oil (100 mg/kg). The treatments were started one day after tumor injection. On day 16, peripheral blood samples of the mice were collected from the retro-orbital plexus under phenobarbital (Aventis Pharma Ltda) for biochemical and hematological analyses, as described below. Then, the animals were euthanized by cervical dislocation, and the tumors were excised and weighed. The drug effects were expressed as the percent inhibition of the control.
Systemic toxicological evaluation
The mice were weighed at the beginning and at the end of the experiment. In addition, the animals were observed for signs of abnormalities throughout the study. Livers, kidneys, spleens, hearts, and lungs were removed, weighed, and observed for any signs of gross lesions or color changes and hemorrhage. Biochemical analyses of serum samples were performed using a Vet-16 rotor and quantified by the Analyst benchtop clinical chemistry system (Hemagen Diagnostics, Inc.). The biochemical parameters measured were alkaline phosphatase, gamma-glutamyl transpeptidase, alanine aminotransferase, albumin, globulin, total protein, urea, uric acid, amylase, creatine kinase, cholesterol, and glucose. Hematological analyses were performed by light microscopy. Hematological parameters, including total count of erythrocytes and leukocytes as well as a differential count of leukocytes, such as neutrophil, lymphocyte, monocyte, eosinophil and basophil, were measured. After a gross macroscopic examination, tumors, livers, kidneys, spleens, hearts, and lungs were fixed in 4 % formalin buffer and embedded in paraffin. Tissue sections were stained for hematoxylin and eosin chromogens, and the analysis was performed under light microscopy by a pathologist.
Statistical analyses
Data are presented as mean ± SEM/SD or half maximal inhibitory concentration (IC 50 ) values and their 95 % confidence intervals obtained by nonlinear regression. The differences between experimental groups were compared by ANOVA (analyses of variance) followed by Student-Newman-Keuls (p < 0.05). All statistical analyses were performed using the GraphPad program (Intuitive Software for Science).
Supporting information
Systemic toxicological parameters (body and organ weights, peripheral blood biochemistry, and hematologic parameters) are available as Supporting Information.
